--- title: "Jacobio Pharmaceuticals Group Co. (1167) stock" url: "https://aibio.space/companies/jacobio-pharmaceuticals/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Jacobio Pharmaceuticals Group Co., Ltd. (HKEX: 1167), China. The directory classifies it as Biotechnology." --- 1167 Jacobio Pharmaceuticals Group Co., Ltd. HKEX · China # Jacobio Pharmaceuticals Group Co. (1167) news Jacobio Pharmaceuticals Group Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1167, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Jacobio Pharmaceuticals Group Co. news We have not published a story on Jacobio Pharmaceuticals Group Co. yet. When there is news, it will appear here. ## Jacobio Pharmaceuticals Group Co. at a glance - **Ticker**: 1167 - **Listing**: HKEX - **Country**: China ### Related companies - [Shanghai Serum Bio-Technology Co.](https://aibio.space/companies/shanghai-serum-bio-technology/) SSE: 688163 - [HJ Science Co.](https://aibio.space/companies/hj-science/) HKEX: 6132 - [Edding Genor Group Holdings](https://aibio.space/companies/edding-genor/) HKEX: 6998 - [Shanghai Shen Lian Biomedical](https://aibio.space/companies/shanghai-shen-lian-biomedical/) SSE: 688098 - [Alphamab Oncology](https://aibio.space/companies/alphamab-oncology/) HKEX: 9966 - [Shanghai ZJ Bio-Tech Co.](https://aibio.space/companies/shanghai-zj-bio-tech/) SSE: 688317 - [Wuxi Biologics (Cayman)](https://aibio.space/companies/wuxi-biologics-cayman/) HKEX: 2269 - [Walvax Biotechnology Co.](https://aibio.space/companies/walvax-biotechnology/) SZSE: 300142 ### Also on HKEX - [Sirnaomics](https://aibio.space/companies/sirnaomics/) 2257 - [China Medical System Holdings](https://aibio.space/companies/china-medical-system/) 867 - [Everest Medicines](https://aibio.space/companies/everest-medicines/) 1952 - [China NT Pharma Group Co.](https://aibio.space/companies/china-nt-pharma/) 1011 - [Tianda Pharmaceuticals](https://aibio.space/companies/tianda-pharmaceuticals/) 455 - [TenNor Therapeutics Suzhou](https://aibio.space/companies/tennor-therapeutics-suzhou/) 6872 ## Questions about Jacobio Pharmaceuticals Group Co. What is the ticker symbol of Jacobio Pharmaceuticals Group Co.? Jacobio Pharmaceuticals Group Co., Ltd. trades under the ticker 1167 on HKEX. Where is Jacobio Pharmaceuticals Group Co. listed? Jacobio Pharmaceuticals Group Co., Ltd. is listed on HKEX. Our directory also records these other listings: LS:A2QK1R. Which country or territory is Jacobio Pharmaceuticals Group Co. listed under? Our directory records Jacobio Pharmaceuticals Group Co., Ltd. under China. What does Jacobio Pharmaceuticals Group Co. do? Our directory classifies Jacobio Pharmaceuticals Group Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Jacobio Pharmaceuticals Group Co.? The ISIN recorded for Jacobio Pharmaceuticals Group Co., Ltd. is KYG4987A1094. Does aibio.space cover Jacobio Pharmaceuticals Group Co.? aibio.space lists Jacobio Pharmaceuticals Group Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Jacobio Pharmaceuticals Group Co.? Companies in our directory listed in the same country and business area as Jacobio Pharmaceuticals Group Co.: Shanghai Serum Bio-Technology Co., HJ Science Co., Edding Genor Group Holdings, Shanghai Shen Lian Biomedical, Alphamab Oncology, Shanghai ZJ Bio-Tech Co.. ## Investor discussion: Jacobio Pharmaceuticals Group Co. Members talk about Jacobio Pharmaceuticals Group Co. (1167). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Jacobio Pharmaceuticals Group Co., newest first. Each line links the filing it comes from. 1. 2026-04-24 Financings Share or debt issue: PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0424/2026042400854.pdf) 2. 2025-05-14 Financings Share or debt issue: PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF DIRECTORS, PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0514/2025051400660.pdf) ## Press releases Headlines of Jacobio Pharmaceuticals Group Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-08-24 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026 AND APPOINTMENT OF VICE CHAIRPERSON OF THE BOARD AND CHANGES IN SENIOR MANAGEMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0824/2026082401425.pdf) 2. 2026-08-10 HKEXnews [POSITIVE PROFIT ALERT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0810/2026081001036.pdf) 3. 2026-07-26 HKEXnews [VOLUNTARY ANNOUNCEMENT JACOBIO COMPLETED FIRST PATIENT DOSAGE IN THE PHASE IIA CLINICAL TRIAL OF BET INHIBITOR JAB-8263 IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN CHINA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0727/2026072700005.pdf) 4. 2026-07-19 HKEXnews [VOLUNTARY ANNOUNCEMENT JACOBIO ANNOUNCES FIRST PATIENT DOSED IN CHINA FOR PHASE IB/III CLINICAL TRIAL OF PAN-KRAS INHIBITOR JAB-23E73 IN COMBINATION WITH CHEMOTHERAPY FOR THE FIRST-LINE THERAPY FOR KRAS-MUTANT PANCREATIC CANCER](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0720/2026072000019.pdf) 5. 2026-06-07 HKEXnews [VOLUNTARY ANNOUNCEMENT INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0608/2026060800011.pdf) 6. 2026-06-05 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 5, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0605/2026060501910.pdf) 7. 2026-05-18 HKEXnews [VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE AND CASH RESERVE UPDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0519/2026051900001.pdf) 8. 2026-04-24 HKEXnews [NOTICE OF 2026 ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0424/2026042400970.pdf) 9. 2026-04-24 HKEXnews [PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0424/2026042400854.pdf) 10. 2026-03-30 HKEXnews [VOLUNTARY ANNOUNCEMENT JACOBIO RECEIVED $100 MILLION UPFRONT PAYMENT FROM ASTRAZENECA UNDER THE LICENSE AND COOPERATION AGREEMENT FOR THE PAN-KRAS INHIBITOR JAB-23E73](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0330/2026033000113.pdf) 11. 2026-03-10 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0310/2026031001456.pdf) 12. 2025-12-21 HKEXnews [INSIDE INFORMATION LICENCE AND COLLABORATION AGREEMENT WITH ASTRAZENECA FOR PAN-KRAS INHIBITOR JAB-23E73](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1221/2025122100421.pdf) 13. 2025-12-02 HKEXnews [VOLUNTARY ANNOUNCEMENT JACOBIO RECEIVED UPFRONT PAYMENT UPON THE CAPITAL INCREASE AGREEMENT AND EQUITY TRANSFER AGREEMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1202/2025120200521.pdf) 14. 2025-11-30 HKEXnews [VOLUNTARY ANNOUNCEMENT JACOBIO'S KRAS G12C AND SHP2 COMBINATION THERAPY PUBLISHED IN THE LANCET RESPIRATORY MEDICINE](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1201/2025120100101.pdf) 15. 2025-11-12 HKEXnews [APPOINTMENT OF CO-CHIEF EXECUTIVE OFFICER](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1113/2025111300003.pdf) 16. 2025-10-23 HKEXnews [VOLUNTARY ANNOUNCEMENT JACOBIO PRESENTED PRECLINICAL DATA OF PAN-KRAS INHIBITOR JAB-23E73 AT THE AACR-NCI-EORTC 2025 INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1024/2025102400003.pdf) 17. 2025-10-15 HKEXnews [VOLUNTARY ANNOUNCEMENT ENTERING INTO THE CAPITAL INCREASE AGREEMENT AND EQUITY TRANSFER AGREEMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1015/2025101501216.pdf) 18. 2025-09-25 HKEXnews [VOLUNTARY ANNOUNCEMENT CHANGE IN SHAREHOLDINGS OF THE PARTIES ACTING IN CONCERT AND UPDATES ON ON-MARKET SHARE REPURCHASE BY THE COMPANY](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0926/2025092600007.pdf) 19. 2025-09-03 HKEXnews [VOLUNTARY ANNOUNCEMENT FURTHER INCREASE SHAREHOLDINGS OF THE PARTIES ACTING IN CONCERT](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0904/2025090400001.pdf) 20. 2025-08-29 HKEXnews [TERMS OF REFERENCE OF THE NOMINATION COMMITTEE](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0829/2025082903592.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:1167 on TradingView](https://www.tradingview.com/symbols/HKEX-1167/). ## Listing details Jacobio Pharmaceuticals Group Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1167, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Jacobio Pharmaceuticals Group Co., Ltd. - **Ticker**: 1167 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Biotechnology - **ISIN**: KYG4987A1094 - **Other listed symbols**: LS:A2QK1R - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-1167/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/jacobio-pharmaceuticals/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Jacobio Pharmaceuticals Group Co. (1167) stock", 2026-10-31, https://aibio.space/companies/jacobio-pharmaceuticals/